Ultrasound to Prevent Leg Wound Complications in Heart Bypass.

An Investigation Into the Efficacy of Pre-operative Long Saphenous Vein Mapping Using Ultrasound for Use in Coronary Artery Bypass Grafting to Reduce Vein Harvest Site Complications.

The long saphenous vein is traditionally harvested for use as a conduit in coronary artery bypass grafting surgery. Currently, the long saphenous vein is not imaged prior to surgery. This study aims to evaluate preoperative ultrasound mapping of the long saphenous vein to to improve patient and clinical outcomes.

Study Overview

Detailed Description

A vein from the leg is widely is widely harvested during coronary artery bypass grafting (CABG) surgery for bypass of diseased coronary arteries. This vein is called the long saphenous vein.

Currently, the long saphenous vein (LSV) is harvested blind by surgical practitioners with no imaging prior to surgery to decide on whether this vein is suitable for use in heart bypass surgery. This can result in fruitless incisions and result in additional unnecessary surgical wounds in the leg(s) to identify a suitable section of vein that can be used in the bypass operation. In these cases, excessive surgical trauma to the leg can increase the risk of a wound infection.

There is some evidence that ultrasound imaging of the LSV improves leg wound outcomes in patients having CABG surgery. Some studies have reported reductions in vein wound infection rates, vein harvest time, length of hospitalisation and length of wounds.

The purpose of this study will be to investigate the potential benefit of ultrasound imaging as a randomised control trial. One group will have ultrasound imaging of the long saphenous vein prior to heart bypass surgery. A second group will not undergo ultrasound imaging which is current practice at the Bristol Heart Institute.

Ultrasound imaging of the long saphenous vein will allow planning and selection of the most optimal segment of vein. This targeted approach will allow guidance of surgical incisions away from unsuitable segments and thus potentially improving leg wound outcomes.

The primary endpoint for this study will be to assess leg wound infection between the two randomised groups. Other endpoints that will be assessed are patient satisfaction, wound length, time taken to remove the vein, blood loss from the leg wound during surgery and the number of wounds in your leg.

Study Type

Interventional

Enrollment (Actual)

55

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bristol, United Kingdom, BS2 8HW
        • University Hospital Bristol NHS FT

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Listed for CABG surgery with long saphenous vein harvesting.
  • Aged over 18 years.
  • Capable of providing informed consent.
  • Five days or more to consider participation prior to surgery if an outpatient or 2 days if an inpatient referred by their consultant.
  • Operative procedure to be undertaken at the Bristol Heart Institute.

Exclusion Criteria:

  • Operation within 48h hours if an inpatient or 5 days if an outpatient.
  • Aged below 18 years of age.
  • Incapable of providing informed consent i.e. confirmed diagnosis of dementia or other mental health conditions or unconscious.
  • Current participant in a different randomised control trial.
  • Pregnancy
  • Active cancer
  • Immunosuppressed.
  • Non-English speaker that requires a Trust translator.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Pre-operative ultrasound imaging
Subjects that are randomly allocated to this group will have ultrasound imaging assessment of the long saphenous vein in both legs. This will allow assessment of the suitability of the long saphenous vein and marking of the distribution prior to heart bypass surgery to allow targeted harvesting of a bypass conduit.
Ultrasound imaging of the long saphenous vein from the ankle to the saphenofemoral junction. This will allow assessment of vein calibre, branches and bifurcations, presence of thrombophlebitis and distribution. The presence of a proximal deep vein thrombosis will also be assessed.
No Intervention: Current protocol
This group will not undergo pre-operative ultrasound imaging of the long saphenous vein in accordance with current Trust protocols.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Surgical site infection at the conduit harvest site
Time Frame: 30 days of CABG surgery
The ASEPSIS tool is a well established tool to quantify wound healing disturbances.
30 days of CABG surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ability to identify abnormal segments of vein on ultrasound and direct surgical excision away from such areas.
Time Frame: baseline
Applicable to the ultrasound imaged group only. The incidence of an abnormal segment of vein will be quantified and whether or not this has led to avoidance of unnecessary surgical excisions.
baseline
Time taken to harvest a suitable conduit.
Time Frame: intraoperative
The time to harvest a suitable conduit will be recorded during CABG surgery.
intraoperative
Length of lower limb vein harvest wounds.
Time Frame: 1 day Post-operation
Length of conduit harvest wounds will be measured after surgery to the nearest centimetre.
1 day Post-operation
Blood loss from the vein harvest wound
Time Frame: intraoperative
The blood loss from the conduit harvest wound(s) will be measured during surgery by weighing swabs.
intraoperative
Patient questionnaire to assess wound/scar satisfaction and complications.
Time Frame: 30 days from surgery
An assessment of patient satisfaction and non-infective complications related to the conduit harvesting for CABG surgery.
30 days from surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Reshat Reshat, PhD, University Hospital Bristol NHS FT
  • Study Director: Teresa Robinson, MSc, University Hospital Bristol NHS FT

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2015

Primary Completion (Actual)

February 13, 2017

Study Completion (Actual)

February 13, 2017

Study Registration Dates

First Submitted

December 1, 2014

First Submitted That Met QC Criteria

December 2, 2014

First Posted (Estimate)

December 3, 2014

Study Record Updates

Last Update Posted (Actual)

May 3, 2019

Last Update Submitted That Met QC Criteria

May 1, 2019

Last Verified

May 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Coronary Artery Bypass

Clinical Trials on Ultrasound imaging of the long saphenous vein

Subscribe